Order Article Reprints

Wahner Hendrickson AE, Visscher DW, Hou X, Goergen KM, Atkinson HJ, Beito TG, Negron V, Lingle WL, Bruzek AK, Hurley RM, et al. CHFR and Paclitaxel Sensitivity of Ovarian Cancer. Cancers. 2021; 13(23):6043. https://doi.org/10.3390/cancers13236043

Wahner Hendrickson, Andrea E., Daniel W. Visscher, Xiaonan Hou, Krista M. Goergen, Hunter J. Atkinson, Thomas G. Beito, Vivian Negron, Wilma L. Lingle, Amy K. Bruzek, Rachel M. Hurley, and et al. 2021. "CHFR and Paclitaxel Sensitivity of Ovarian Cancer" Cancers 13, no. 23: 6043. https://doi.org/10.3390/cancers13236043

Wahner Hendrickson, A. E., Visscher, D. W., Hou, X., Goergen, K. M., Atkinson, H. J., Beito, T. G., Negron, V., Lingle, W. L., Bruzek, A. K., Hurley, R. M., Wagner, J. M., Flatten, K. S., Peterson, K. L., Schneider, P. A., Larson, M. C., Maurer, M. J., Kalli, K. R., Oberg, A. L., Weroha, S. J., & Kaufmann, S. H. (2021). CHFR and Paclitaxel Sensitivity of Ovarian Cancer. Cancers, 13(23), 6043. https://doi.org/10.3390/cancers13236043